About KIRAGEN BIO INC
KiraGen Bio is a biotechnology company focused on developing off-the-shelf cell therapies that resist tumor microenvironment suppression through multiplex gene editing. The company aims to create durable and scalable cell therapies for solid tumors.
Multiplex precision gene editingDevelopment of off-the-shelf donor-derived cell therapiesAI-driven optimization of gene edits and CAR-T therapiesTME-Guarded designs for durable functionExpertise in synthetic biology and tumor immunosuppression
Is this your company?
Claim KIRAGEN BIO INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim KIRAGEN BIO INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.